ERIN KRSTANOVIC: Open Payments
NPI 1588317572 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 77 payments from 19 companies in 2025. Trend: 2023 $1,759 · 2024 $1,857 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $480 |
| GENZYME CORPORATION | 9 | $245 |
| Madrigal Pharmaceuticals | 8 | $219 |
| Regeneron Healthcare Solutions, Inc. | 9 | $176 |
| Lilly USA, LLC | 4 | $172 |
| Janssen Biotech, Inc. | 4 | $97 |
| PFIZER INC. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Fresenius Kabi USA, LLC | 4 | $75 |
| Ardelyx, Inc. | 3 | $73 |
Products named: DUPIXENT, SKYRIZI, REZDIFFRA, OMVOH, RINVOQ, TREMFYA, IBSRELA, Adalimumab-aacf.
Industry payments across MD — which companies pay providers there.
